Male Herpes Guide: Symptoms, Treatment, Prevention

Male herpes is caused by two related viruses: herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2). HSV-1 historically caused most oral herpes (“cold sores”) and HSV-2 most genital herpes, but with the rise of oral sex, cross-site infection has become common and the strict type/site division no longer holds.

According to Japan’s Ministry of Health, Labour and Welfare surveillance, approximately 9,000 new genital herpes cases are formally diagnosed each year in Japan, but this represents the tip of the iceberg. Many patients have minimal or no symptoms and never seek care, and the true number of carriers is estimated to be more than 10 times higher. Men typically have milder symptoms than women, and asymptomatic viral shedding from carriers is a major driver of unrecognized transmission.

The hallmark of HSV is lifelong latency in sensory ganglia with periodic reactivation triggered by reduced host immunity. Antibodies do not eliminate the virus — a feature shared by other Herpesviridae such as varicella-zoster virus (VZV) and HIV.

Male herpes typically presents with painful, grouped vesicles that progress to ulceration over several days. Genital herpes is most often seen on the glans, foreskin, shaft, scrotum, or perianal skin; oral herpes appears on the lip border or perioral skin. Initial outbreaks are usually severe with systemic symptoms (fever, malaise, lymphadenopathy); recurrences are typically milder and shorter, often preceded by tingling or itching prodromes.

HSV is transmitted by direct contact between mucous membranes or breaks in the skin. Genital HSV transmission is most common via vaginal/anal intercourse and oral sex; oral HSV typically spreads via kissing or shared utensils. Importantly, asymptomatic viral shedding from carriers is responsible for a substantial proportion of new infections, since the virus may be present on the skin without visible lesions.

The typical incubation period is 2–12 days, with most cases manifesting at 3–7 days. Some patients become long-term asymptomatic carriers, with the first clinical episode appearing months or years after the actual infection event.

Diagnosis of male herpes is primarily clinical, based on characteristic vesicular lesions and patient history. For confirmation or atypical presentations, HSV PCR testing of lesion swabs (sensitivity >95%) is the gold standard, with results in 1–3 days. Type-specific serology (IgG) can identify HSV-1 vs HSV-2 antibodies but cannot distinguish recent vs remote infection.

The standard treatment for male herpes is oral antiviral therapy with valacyclovir, acyclovir, or famciclovir. Three regimens exist: episodic therapy (start at the first sign of an outbreak, 5–10 days), suppressive therapy (daily continuous use to prevent recurrences), and initial-episode therapy (extended treatment course for first outbreak).

Untreated herpes can lead to severe pain, urinary retention, partner transmission, increased HIV acquisition risk (2–3x), and rarely meningitis or proctitis. The pain itself can severely impact daily life — there are documented cases of patients unable to walk or urinate normally during severe outbreaks.

• Severe pain, urinary difficulty during outbreaks
• HIV acquisition risk increased 2–3 fold per WHO data
• Transmission to sexual partners
• Rare meningitis (especially primary infection)
• Maternal-fetal transmission causing neonatal herpes
• Genital herpes increases proctitis risk in MSM

Reducing herpes recurrences relies on identifying and avoiding triggers, optimizing immune function, and using suppressive therapy when frequency exceeds 6 episodes/year.

• Adequate sleep, stress reduction, regular exercise
• Avoid excessive UV exposure (oral herpes trigger)
• Maintain healthy weight, avoid excessive alcohol
• Use sunscreen on lips for HSV-1 carriers
• Treatment of underlying immunosuppression
• Suppressive antivirals if >6 outbreaks/year or partner protection

Genital herpes is associated with significant psychological impact including ED, decreased libido, and relationship distress. The virus itself does not impair erectile mechanisms; rather, anxiety about transmission, fear of recurrence pain, and relationship guilt produce psychogenic ED. Treatment combines suppressive antivirals with PDE5 inhibitors when needed.

Men’s Care Clinic is a men’s-only specialty clinic providing STD, ED, and AGA care in a one-stop format. Same-day PCR diagnosis, prompt antiviral prescription, online consultation follow-up. Private rooms and male-staff-led environment.

• Men-only: Male physicians and staff
• Private rooms: No contact with other patients
• Same-day PCR + antivirals
• Online consultation: Suppressive refills
• STD + ED + AGA integrated
• Toyosu Hospital partnership: Tertiary backup

Common questions from Men Care Clinic patients about male herpes, answered by our physicians.